Poor adherence to treatments: A fundamental principle of dermatology

Archives of Dermatology

Volumn 143, Issue 7, 2007, Pages 912-915

  Ali, Saba M ^b   Brodell, Robert T ^b   Balkrishnan, Rajesh ^b   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; PYRITHIONE ZINC; STEROID;

ATOPIC DERMATITIS; CLINICAL TRIAL; DISEASE SEVERITY; EDUCATION; HOSPITAL PATIENT; HUMAN; NEUROIMMUNOLOGY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACOGENOMICS; PHYSICIAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; TACHYPHYLAXIS; TREATMENT OUTCOME;

BIOLOGICAL RESPONSE MODIFIERS; DERMATOLOGY; HUMANS; PSORIASIS; PUVA THERAPY; TREATMENT REFUSAL;

EID: 34447550756     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.7.912     Document Type: Review

References (35)

1. Jones-Caballero M, Unaeze J, Penas PF, Stern RS. Use of biological agents in patients with moderate to severe psoriasis: a cohort-based perspective. Arch Dermatol. 2007;143(7):846-850.
2. Maibach HI, Stoughton RB. Topical corticosteroids. Med Clin North Am. 1973;57(5):1253-1264.
3. Solomon AE, Lowe NJ. Percutaneous absorption in experimental epidermal disease. Br J Dermatol. 1979;100(6):717-722.
4. Serup J, Blichmann C. Epidermal hydration of psoriasis plaques and the relation to scaling: measurement of electrical conductance and transepidermal water loss. Acta Derm Venereol. 1987;67(4):357-359.
5. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol. 1992;127(1):13-17.
6. Jobling RG. Psoriasis: a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol. 1976;1(3):233-236.
7. Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581-583.
8. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408-414.
9. Krejci-Manwaring J, McCarty MA, Camacho F, et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006;54(5)(suppl):S235-S236.
10. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol. 2003;49(4):651-654.
11. Shelley WB, Shelley ED. A dermatologic diary: portrait of a practice. Cutis. 1997;59(4):181-182.
12. Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol. 2006;5(6):527-532.
13. de Groot M, Appleman M, Spuls PI, de Rie MA, Bos JD. Initial experience with 280 routine administration of etanercept in psoriasis. Br J Dermatol. 2006;155(4):808-814.
14. Kragballe K, Gjertsen BT, De Hoop D, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet. 1991;337(8735):193-196.
15. Lebwohl M, Siskin SB, Epinette W, et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol. 1996;35(2, pt 1):268-269.
16. Feldman SR, Fleischer AB Jr, Cooper JZ. New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care. Int J Dermatol. 2000;39(1):41-44.
17. Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607-613.
18. Modell JG, Boyce S, Taylor E, Katholi C. Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med. 2002;64(5):835-840.
19. Renzi C, Tabolli S, Picardi A, Abeni D, Puddu P, Braga M. Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol. 2005;19(6):712-718.
20. Pittelkow MR, Benson LM, Naylor S, Tomlinson AJ. Detection of corticosteroid in an over-the-counter product. JAMA. 1998;280(4):327-328.
21. Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB Jr, Feldman SR. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol. 2003;49(1):79-82.
22. Mikhail M, Scheinfeld N. Evidence-based review of topical treatments for psoriasis. Dermatology. 2004;4:423.
23. DermNet NZ. Treatment of atopic dermatitis. http://dermnetnz.org/ dermatitis/treatment.html. Accessed October 2006.
24. US Food and Drug Administration. Psoriasis: more than cosmetic. http://www.fda.gov/fdac/features/2004/504_psoriasis.html. Accessed October 2006.
25. du Vivier A, Stoughton RB. Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol. 1975;111(5):581-583.
26. Miller JJ, Roling D, Margolis D, Guzzo C. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis. J Am Acad Dermatol. 1999;41(4):546-549.
27. Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol. 2006;24(3):229-230.
28. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212-216.
29. Baldwin HE. Tricks for improving compliance with acne therapy. Dermatol Ther. 2006;19(4):224-236.
30. Chren MM. Doctor's orders: rethinking compliance in dermatology. Arch Dermatol. 2002;138(3):393-394.
31. Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat. 2006;17(3):136-142.
32. Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement: implications for dermatology. Am J Clin Dermatol. 2001;2(1):7-12.
33. Lee IA, Maibach HI. Pharmionics in dermatology a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231-236.
34. Serup J, Lindblad AK, Maroti M, et al. To follow or not to follow dermatological treatment: a review of the literature. Acta Derm Venereol. 2006;86(3):193-197.
35. Soares TF, Davis MDP. Success of Goeckerman treatment in 2 patients with psoriasis not responding to biological drugs. Arch Dermatol. 2007;143(7):950-951.